Neuroprotective Effect of (Nano PSO), in Patients Who Used to Consume Psychoactive Substances
Recruiting
N/A
Interventional Study
Addiction;Drug(S);LSD
Neuroprotective
At a Glance
- Age
- 18 – 50
- Sex
- Male
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 80 (estimated)
- Sponsor
- Distribuidora Biolife SA de CV · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Addiction problems to psychoactive substances are becoming more frequent, which implies a serious health problem, with social, family and work repercussions. Participants with chronic consumption present important degeneration processes mediated by Neuroinflammation, oxidative stress and excitotoxicity. At the moment there is no effective treatment that can reduce the damage. The effectiveness of …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients who are multiple users of methamphetamines, cocaine, and cannabis with or without alcohol and tobacco, and have a history of at least 3 years of consumption.
* Patients who accept informed consent to participate in the protocol.
* Male gender.
* Age between 18-50 year…
Contacts